CAS: 10309-37-2; (S,E)-4-(3,7-Dimethyl-3-Vinylocta-1,6-Dien-1-yl)Phenol

该化合物是一种植物衍生的视质醇替代品,可增强时用配方的稳定性和功效,它显示了对视质醇类似的皮肤-惠益性能,包括激素生产刺激,细胞更替增强和抗氧化剂活动,同时为敏感的皮肤类型提供了更好的耐受性和减少刺激的可能性.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报

上下游产品

(+/-)-bakuchiol methyl ether 6-Methyl-hept-5-en-2-on 3,7-dimethyl-°Ct-6-en-1-yn-3-yl methyl carbonate Geraniol 7,8,16,17-tetrahydrobakuchiol 7,8-dihydrobakuchiol 4-(3-ethyl-3,7-dimethyl°Ctyl)phenol (S,E)-4-(3,7-dimethyl-3-vinyl°Cta-1,6-dien-1-yl)phenyl acetate

合成工艺路线路线简述

    香叶基溴置于吡啶,Chromium Dichloride,锰,甲基碘化镁,二氯二茂锆,3,4,5-Trifluoro-N-(2-((S)-4-Isopropyl-4,5-Dihydrooxazol-2-yl)-6-(((1S,2R,5S)-2-Isopropyl-5-Methylcyclohexyl)Oxy)Phenyl)Benzenesulfonamide,甲基磺酰氯,Nickel Dichloride,Cesium Iodide体系中,用 四氢呋喃 用作溶剂,化学反应 25.17H,反应生成补骨脂酚
    参考文献:铬催化对映选择性合成四元立体中心
    标题:铬催化对映选择性合成四元立体中心
    摘要:在磺酰胺/恶唑啉铬配合物的存在下,已经实现了醛与γ-二取代的烯丙基卤的不对称烯丙基化.可以以高度非对映选择性和对映选择性的方式获得具有两个连续的立体生成中心(包括一个季碳)的各种合成上有用的α-均丙醇.
    Doi:10.1021/acs.Orglett.6B02540

    海关参考信息

    专利信息


    专利号:US-3857842-A
    优先权日:1970-05-06
    标题:Process for preparing purine compounds by reaction of a carbonitrile with formic acid
    发明人:ASAI N
    权利人:SAGAMI CHEM RES
    摘要:An improved process for preparing purine compounds of the formula WHEREIN X is selected from the group consisting of an amino and a hydroxy group, and Y is selected from the group consisting of an amino and a hydroxy group and hydrogen, which are useful as precursors for the synthesis of organic compounds, as well as a process for preparing a carboxyamide of the formula USEFUL AS AN INTERMEDIATE FOR THE SYNTHESIS OF THE ABOVE PURINE COMPOUNDS ARE

    专利号:US-2008187918-A1
    优先权日:2004-11-19
    标题 :Method of Diagnosing the Risk of Thermolabile Phenotype Diseases by Using Gene
    发明人:KIDO HIROSHI; KINOSHITA MORITOSHI; MIZUGUCHI HIROSHI; TAKAHASHI NORIHIKO
    权利人:OTSUKA PHARMA CO LTD; UNIV TOKUSHIMA
    摘要:The invention relates to a method of diagnosing a risk of a thermolabile phenotype disease including or caused by influenza encephalitis/encephalopathy, Reye's syndrome, RS virus infectious disease, adenovirus infectious disease, rhinovirus infectious diseases, bastard measles, Japanese encephalitis, malaria infectious disease, Kawasaki disease and sudden infant death syndrome, characterized by examining whether or not an enzymatic activity of at least one enzyme involved in any of various transporters, carnitine cycle, long-chain β oxidation cycle, medium-chain/short-chain β oxidation cycle, electron transfer, synthesis of a ketone and production of ATP involved in energy metabolism in mitochondria is significantly lower compared with healthy subjects at 39° C. or higher when referring the enzymatic activity at 37° C. as to 100%.

    专利号:US-9079951-B2
    优先权日:2005-09-08
    标 题 :Method for production of vitamin C
    发明人:CHEVREUX BASTIEN; HAUK CORINA; MUFFLER ANDREA; MOUNCEY NIGEL J; SHINJOH MASAKO
    权利人:CHEVREUX BASTIEN; HAUK CORINA; MUFFLER ANDREA; MOUNCEY NIGEL J; SHINJOH MASAKO; DSM IP ASSETS BV
    摘要:The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to the use of the polynucleotides and polypeptides as biotechnological tools in the production of Vitamin C from microorganisms, whereby a modification of the polynucleotides and/or encoded polypeptides has a direct or indirect impact on yield, production, and/or efficiency of production of the fermentation product in the microorganism. Also included are methods/processes of using the polynucleotides and modified polynucleotide sequences to transform host microorganisms. The invention also relates to genetically engineered microorganisms and their use for the direct production of Vitamin C.

    专利号:US-3948726-A
    优先权日:1973-10-01
    标题:Production of cephalosporin C
    发明人:KANZAKI TOSHIHIKO; FUJISAWA YUKIO; SUIDE HARUO
    权利人:TAKEDA CHEMICAL INDUSTRIES LTD
    摘要:A new process for the production of Cephalosporin C (CPC) in which a polyene-antibiotics-resistant mold of the genus Cephalosporium is employed and an increased yield is attained. n Cpc is an antibiotic and also useful as a starting material for the synthesis of Cephalosporin-group antibiotics.

    专利号:WO-2006084730-A1
    优先权日:2005-02-11
    标题:Oxidoreductase gene from the respiratory chain system of gluconobacter oxydans
    发明人:CHEVREUX BASTIEN; MAYER ANNE FRANCOISE; MEURY ANJA; MOUNCEY NIGEL JOHN; SHINJOH MASAKO
    权利人:DSM IP ASSETS BV; CHEVREUX BASTIEN; MAYER ANNE FRANCOISE; MEURY ANJA; MOUNCEY NIGEL JOHN; SHINJOH MASAKO
    摘要:The present invention relates to newly identified genes that encode proteins with oxidoreductase activity (e.g. EC 1.10) that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C) . The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to the use of said polynucleotides and polypeptides as bioteσhnological tools in the production of Vitamin C from microorganisms, whereby a modification of said polynucleotides and/or encoded polypeptides has a direct or indirect impact on yield, production, and/or efficiency of production of the fermentation product in said microorganism. Also included are methods/processes of using the polynucleotides and modified polynucleotide sequences to transform host microorganisms. The invention also relates to genetically engineered microorganisms and their use for the direct production of Vitamin C.

    专利号:US-3808225-A
    优先权日:1970-12-09
    标 题:Process for the preparation of 4(5)-cyanoimidazole-5(4)-carboxyamide by reacting diaminomaleonitrile with formic acid
    发明人:ASAI N
    权利人:SAGAMI CHEM RES
    摘要:AN IMPROVED PROCESS FOR THE PREPARATION OF 4(5)-CYANOIMIDAZOLE-5(4)-CARBOXYAMIDE OF THE FORMULA 4-(NC-),5-(NH2-CO-)IMIDAZOLE WHICH IS USEFUL AS A PRECUSOR FOR THE SYNTHESIS OF VARIOUS COMPOUNDS COMPRISING REACTING DIAMINOMALEONITRILE OF THE FORMULA NC-C(-NH2)=C(-NH2)-CN WITH FORMIC ACID IN AN AROMATIC SOLVENT IS DISCLOSED.
    常州市宣明医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://xuanmingchem.com
    企业联系电话:0519-85525329👤
    📞常州市宣明医药科技有限公司 ⚠️参考联系方式
    联系人:刘明;许雯
    电话:0519-85525329
    手机:15951231113;13646117943
    传真:0519-85190960
    邮箱:sales@xuanmingchem.com
    通信地址: 江苏省常州市新北区汉江路120号
    邮编: 213000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市新北区汉江路120号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    无锡景耀生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jingyaobiotech.com
    企业联系电话:0510-88770633👤
    📞无锡景耀生物科技有限公司 ⚠️参考联系方式
    联系人:王正智
    电话:0510-88770633
    手机:13961738808;15161581380
    传真:0510-88770633
    邮箱:jingyaobiotech@126.com
    通信地址: 无锡市锡山区东港镇兴港北路237号
    邮编: 214199
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:无锡市锡山区东港镇兴港北路237号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Shoji M, Arakaki Y, Esumi T, Kohnomi S, Yamamoto C, Suzuki Y, Takahashi E, Konishi S, Kido H, Kuzuhara T. Bakuchiol Is a Phenolic Isoprenoid with Novel Enantiomer-selective Anti-influenza A Virus Activity Involving Nrf2 Activation. J Biol Chem. 2015 Nov 13;290(46):28001-17. doi: 10.1074/jbc.M115.669465. Epub 2015 Oct 7.
    2: Mao H, Wang H, Ma S, Xu Y, Zhang H, Wang Y, Niu Z, Fan G, Zhu Y, Gao XM. Bidirectional regulation of bakuchiol, an estrogenic-like compound, on catecholamine secretion. Toxicol Appl Pharmacol. 2014 Jan 1;274(1):180-9. doi: 10.1016/j.taap.2013.11.001. Epub 2013 Nov 11. doi: 10.1016/j.bbrc.2016.03.127. Epub 2016 Mar 28. doi: 10.1016/j.fitote.2015.09.005. Epub 2015 Sep 5. doi: 10.1155/2015/918624. Epub 2015 Nov 8.
    7: Kim JE, Kim JH, Lee Y, Yang H, Heo YS, Bode AM, Lee KW, Dong Z. Bakuchiol suppresses proliferation of skin cancer cells by directly targeting Hck, Blk, and p38 MAP kinase. Oncotarget. 2016 Mar 22;7(12):14616-27. doi: 10.18632/oncotarget.7524.

    合成参考文献


    参考文献:10.2174/157016310791162785
    摘要:Yang H, Liu J, Dou QP. Targeting tumor proteasome with traditional Chinese medicine. Curr Drug Discov Technol. 2010 Mar;7(1):46–53.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知